$28.990
0.000 (0.00%)At close
ALOT News
ALOT Events
AstroNova Shareholders Approve Acquisition at $29.00
AstroNova announced that at a Special Meeting of shareholders held virtually earlier today, its shareholders voted to approve the acquisition of the Company by Arcline Investment Management. Jorik Ittmann, President and CEO of AstroNova, said, "We are pleased to have reached this important milestone and appreciate the support of our shareholders. As we begin AstroNova's next chapter, we look forward to partnering with Arcline and drawing on its deep experience and institutional capabilities to build on the strengths of our businesses and position them for long-term growth." More than 99% of the votes cast at the special meeting of shareholders voted in favor of the merger agreement representing approximately 64% of all issued and outstanding shares of AstroNova common stock as of the July 29, 2026 record date. A majority of shares outstanding in favor of the transaction was required for approval. Under the terms of the Agreement and Plan of Merger, dated as of June 16, 2026, by AstroNova and affiliates of Arcline Investment Management, shareholders will receive $29.00 per share in cash in connection with the closing of the transaction which is expected to be completed on August 26, 2026. AstroNova will become a privately held company, and its common stock will no longer be traded on the Nasdaq.
AstroNova to be Acquired by Arcline for Approximately $272M
AstroNova entered into a definitive agreement to be acquired by Arcline Investment Management in an all-cash transaction with a total enterprise value of approximately $272M; AstroNova shareholders will receive $29.00 per share in cash. Upon completion of the transaction, AstroNova will become a privately held company. The transaction was unanimously approved by AstroNova's Board of Directors and follows the Company's previously announced review of strategic alternatives intended to maximize shareholder value. The per share purchase price represents a premium of approximately 209% over AstroNova's unaffected closing share price on April 6, the last full trading day prior to the strategic alternatives review announcement, and a premium of approximately 120% over the volume weighted average price of AstroNova common stock for the 90 days ending June 16. The transaction requires approval by AstroNova stockholders and is expected to close in the third quarter of 2026, subject to customary closing conditions including receipt of regulatory approvals.
Astro Med Trading Halted, News Pending
Astro Med trading halted, news pending
Nasdaq Futures Rise 1.53% as Semiconductor Stocks Rebound
Stock futures are higher this morning as markets attempt to stabilize after Friday's sharp technology selloff. S&P 500 and Nasdaq futures are particularly rebounding, led by gains in semiconductor stocks, which are recovering some of the roughly $1T in market value erased from the chip sector late last week.Friday's employment report showed the labor market continues to create jobs despite elevated interest rates. That data reinforced the view that the economy is slowing gradually rather than falling into recession. For equity investors, that is generally positive for earnings, but it also complicates the outlook for Federal Reserve policy. Treasury yields remain elevated as a result, although they have stabilized somewhat after their sharp rise during May.Oil prices are receiving less attention than they were a few weeks ago, but energy remains an important variable.In pre-market trading, S&P 500 futures rose 0.81%, Nasdaq futures rose 1.53% and Dow futures rose 0.29%.Check out this morning's top movers from around Wall Street, compiled by The Fly.HIGHER -Corningup 9% after Amazonannounced a "multibillion-dollar agreement" for Corning to supply the optical fiber, cable, and connectivity solutions for Amazon's expanding data center infrastructure across the United States.Noceraup 39% after entering into a binding agreement with U.S.-based Digital Innovations Group to establish Digital Innovations Venture Group, a strategic venture platformNurix Therapeuticsup 15% after announcing a global collaboration with Rocheto develop and commercialize bexobrutidegNvidiaup 2% after reporting a multiyear technology partnership with SK Hynix to advance next-generation memory for the global AI factory buildout and accelerate semiconductor design and manufacturingEli Lillyup 1% after presenting results demonstrating that women with obesity or overweight who took the highest dose of Foundayo experienced significant weight loss at every stage of menopauseUP AFTER EARNINGS -AstroNovaup 6%FuelCellup 4%Duluth Holdingsup 3%Campbell'sup 2%DOWN AFTER EARNINGS -Grahamdown 7%LOWER -Wixdown 11% after cutting its FY26 revenue outlook citing an organizational realignment that includes discontinuation of certain activitiesStandard Biotoolsdown 3% after the company and Treeline Biosciences announced they have entered into a definitive merger agreement to combine in an all-stock transaction
Q1 Revenue Reaches $39.4M
Reports Q1 revenue $39.4M…
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.